Search

everythinglearnresearchcommunity

for

Search:↓

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

The Trust tonic is more effective than minoxidil for treating hair loss.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Caffeine may help reduce stress-induced hair loss.

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Dermoscopy improves accuracy in predicting treatment success for androgenetic alopecia with the Regenera® protocol.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Retinoic acid helps activate hair growth in people with common hair loss by working on a specific cell growth pathway.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

Iontophoresis with a growth factor cocktail helps hair growth in patients with androgenetic alopecia.

CEOs aged 50-69 have less significant hair loss than the general white male population.

CEOs aged 50-69 have less significant hair loss than the general white male population.

PRP with microneedling is more effective than PRP alone for treating hair loss.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The new Cosmetic Surgery Scar Assessment Scale (CSSAS) was found to be simple and effective in evaluating scars from hair restoration surgeries.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

Type 2 diabetes may increase the risk of severe hair loss in African American women.